Swara Baby Products IPO 2026: FirstCry-Backed Hygiene Manufacturer Files ₹1,000 Crore DRHP with SEBI

India's largest disposable hygiene contract manufacturer is heading to the public markets. On July 2, 2026, Swara Baby Products Limited, backed by FirstCry's parent Brainbees Solutions, filed its Draft Red Herring Prospectus (DRHP) with SEBI for a ₹1,000 crore IPO — giving investors a rare chance to bet directly on India's booming baby care and hygiene manufacturing sector.

Most people know FirstCry as the place to buy diapers. Swara Baby is the company that actually makes them.

What Is the Swara Baby Products IPO, and How Big Is It?

The Swara Baby Products IPO is a combination of a Fresh Issue and an Offer for Sale (OFS), equally split at ₹500 crore each.

Swara Baby Products IPO issue size is ₹1,000 crore in total — ₹500 crore fresh issue (money goes to the company) and ₹500 crore OFS (money goes to selling shareholders). The Swara Baby IPO price band, Swara Baby IPO open date, and Swara Baby IPO listing date are yet to be announced and will be confirmed after SEBI's review and the filing of the Red Herring Prospectus (RHP).

Who Is Selling — and Who Stays?

Brainbees Solutions Limited (FirstCry's parent) is the largest shareholder with a 76.59% stake and is selling shares worth up to ₹300 crore through the OFS. Anadya Bon Merchari LLP will sell shares worth up to ₹200 crore, making up the remaining OFS.

This is not a full exit by Brainbees — it retains a majority stake post-IPO. The OFS is more of a partial monetisation move to unlock value while keeping strategic control over its manufacturing subsidiary intact.

What Does Swara Baby Products Actually Do?

Swara Baby is not a consumer brand you'd spot on a supermarket shelf — it's the factory behind the brands you already buy.

Founded in 2016 and based in Pithampur, Madhya Pradesh, the company is India's largest contract manufacturer of disposable hygiene products by value (FY25). It makes baby pant-style and tape-style diapers, adult incontinence products, sanitary napkins, panty liners, and wet wipes — manufactured for domestic and multinational brands on a white-label basis.

Its client list includes Brainbees Solutions (BabyHug and Eldiapers brands), Piramal Pharma, and Himalaya Wellness Company, among others. Brainbees alone contributed ₹263.46 crore — around 22.64% of FY26 topline — making it the anchor client.

Beyond contract manufacturing, the company also sells under its own brands — Cuddles for baby diapers and Shields for adult diapers — through online channels and modern trade partners like Vishal Mega Mart.

It operates 4 fully automated manufacturing facilities across Pithampur and Indore, with an installed annual capacity of 2,660 million baby diapers, 253 million adult diapers, and 756 million sanitary napkins. In FY25, Swara Baby held a 37% market share in baby diaper contract manufacturing and a 36% market share in adult diaper contract manufacturing — by value.

Swara Baby Products Financials: Profitable and Growing

Key Risks to Know

• Client concentration — Brainbees Solutions (FirstCry) alone contributes over 22% of revenue. Any change in their relationship or sourcing strategy directly impacts Swara Baby's topline.
• Geography concentration — All four manufacturing plants are in Madhya Pradesh. Any disruption — power, logistics, regulatory — affects the entire production base.
• Commodity input risk — Disposable hygiene products rely heavily on SAP (super-absorbent polymer) and nonwoven fabric, prices of which can be volatile and import-dependent.
• Brainbees parent's own challenges — Brainbees Solutions stock has fallen over 21% in 2026. Parent company health matters when it's also your largest customer.
• Competitive intensity — The hygiene contract manufacturing space is attracting new entrants. Maintaining 37% market share while also building a B2C brand is a tough dual track.

Swara Baby IPO Open Date, Listing Date & What Happens Next

SEBI will now review the DRHP — a process typically taking 30 to 75 days. Once SEBI issues its observations, Swara Baby will file the RHP with the final Swara Baby IPO price band, after which the Swara Baby IPO open date will be confirmed.

Swara Baby IPO listing date on both BSE and NSE is expected in late 2026, subject to market conditions and regulatory approvals.

JM Financial and Avendus Capital are the book-running lead managers, with MUFG Intime India as the registrar to the issue.

Conclusion

India's organised hygiene market is projected to grow at a CAGR of 12.7% across key product categories. Baby diapers (52.1%) and feminine hygiene products (40.1%) dominate the addressable market — and both are still massively underpenetrated compared to global benchmarks.

Swara Baby sits at the intersection of two powerful macro trends: rising household spending on baby care, and the shift from unorganised to organised hygiene manufacturing. As a profitable, scaled contract manufacturer with anchor clients, a growing own-brand portfolio, and fresh capital earmarked for expansion — it's a different kind of IPO story from the loss-making startups dominating recent headlines.

The real question for investors will be the price band and the valuation multiple it implies. Watch for the RHP filing for that answer.

-Bigul Research Desk

Bonanza Portfolio Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000212137 | SEBI Regn. No. DP: IN-DP-62-2015 | PMS: INP 000000985 | Research Analyst ID: INH100001666)